Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma Therapy
Scientists at National Heart and Lung Institute, Imperial College publish research in asthma therapy
April 11th, 2007
A report, "Scientific rationale for using a single inhaler for asthma control," is newly published data in European Respiratory Journal. "Clinical trials have recently demonstrated that using a budesonide/formoterol combination inhaler as regular maintenance treatment twice daily but also as a rescue therapy for breakthrough symptoms can provide more effective control of asthma, particularly in reducing exacerbations, than using a short-acting beta2-agonist or formoterol as rescue therapy. This suggests that the corticosteroid component of the combination therapy plays an important role in rescue therapy," investigators in London, the United Kingdom report. ...
Source: Immunotherapy Weekly (2007-04-11)
|
